These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8791240)

  • 21. Effect of subcutaneous sumatriptan on head temperature in migraines.
    Parrinello G; Paterna S; Di Pasquale P; Pinto A; Cardinale A; Maniscalchi T; Cottone C; Follone G; Tuttolomondo A; Bologna P; Colomba D; D'Angelo A; Ortoleva A; Garofalo L; Piovana G; Capodieci E; Bova A; Giubilato A; Licata G
    Drugs Exp Clin Res; 1998; 24(4):197-205. PubMed ID: 10051966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
    Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE
    JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a pragmatic migraine model for drug testing: I. Cilostazol in healthy volunteers.
    Hansen EK; Guo S; Ashina M; Olesen J
    Cephalalgia; 2016 Feb; 36(2):172-8. PubMed ID: 25934317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study.
    Lipton RB; McGinley JS; Shulman KJ; Wirth RJ; Buse DC
    Headache; 2017 Nov; 57(10):1570-1582. PubMed ID: 28880380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study.
    Tfelt-Hansen P; Bach FW; Daugaard D; Tsiropoulos I; Riddersholm B
    J Headache Pain; 2006 Dec; 7(6):389-94. PubMed ID: 17164991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study.
    Landy S; Munjal S; Brand-Schieber E; Rapoport AM
    J Headache Pain; 2018 Aug; 19(1):69. PubMed ID: 30112726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Succinate sumatriptan evaluation by Doppler echocardiography in patients with migraine.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Bucca V; Cecala M; Cardinale A; Maniscalchi T; Tuttolomondo A; Bova A; Arrostuto A; Follone G; Bologna P; Piovana G; Licata G
    Drugs Exp Clin Res; 1998; 24(3):159-63. PubMed ID: 9825232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.
    Visser WH; Burggraaf J; Muller LM; Schoemaker RC; Fowler PA; Cohen AF; Ferrari MD
    Clin Pharmacol Ther; 1996 Oct; 60(4):452-60. PubMed ID: 8873693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack].
    Prusiński A; Król F
    Pol Merkur Lekarski; 1998 Mar; 4(21):158-61. PubMed ID: 9640070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Plosker GL; McTavish D
    Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan.
    Ferrari MD; Haan J; Blokland JA; Arndt JW; Minnee P; Zwinderman AH; Pauwels EK; Saxena PR
    Arch Neurol; 1995 Feb; 52(2):135-9. PubMed ID: 7848120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the effects of sumatriptan on myocardial perfusion in healthy female migraineurs using 13NH3 positron emission tomography.
    Lewis PJ; Barrington SF; Marsden PK; Maisey MN; Lewis LD
    Neurology; 1997 Jun; 48(6):1542-50. PubMed ID: 9191764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral sumatriptan for the long-term treatment of migraine: clinical findings.
    Rederich G; Rapoport A; Cutler N; Hazelrigg R; Jamerson B
    Neurology; 1995 Aug; 45(8 Suppl 7):S15-20. PubMed ID: 7644080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.